McGuireWoods litigation partner Chelsea Hilliard joined Dorsey & Whitney, which is growing its litigation team in Dallas.
A federal court dismissed securities fraud claims against Visa after the stock quickly rebounded from DOJ antitrust allegations, underscoring how ...
"About half of securities class actions are thrown out by the courts at the motion to dismiss stage, thus avoiding costly discovery and a potential settlement. This week’s article, by my colleague and ...
TipRanks on MSN
Early-stage victory: How defense strategy defeated securities class action against HUMBL
Complex securities class actions rarely end quickly, but when fundamental legal requirements remain unmet despite multiple attempts, even the most ...
Thus far, settlement data indicate that during the second half of 2025, shareholders have reached settlements in 20 private Rule 10b-5 securities class actions amounting to $856 million, with an ...
Securities class action filings remained elevated in 2025, signaling that robust activity will likely persist into 2026. According to economic ...
NEW YORK - October 6, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in Fortinet, Inc. (NYSE: FTNT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover ...
or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. CASE DETAILS: The filed complaint alleges that ...
Kirby McInerney LLP reminds investors who purchased agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL) securities to ...
NEW YORK and NEW ORLEANS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- (“KSF”) and KSF partner, former Attorney General of Louisiana, ...
Foti, Jr., remind investors with substantial losses that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sprouts Farmers Market, Inc.
AUSTIN, Texas, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results